Clinical Trial Update: Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated whether hydroxychloroquine could reduce progression from prediabetes to type 2 diabetes; the study has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Plaquenil (hydroxychloroquine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Pre-diabetes | Phase 4 | Status: COMPLETED | Results posted: 2016-01-29